2017
DOI: 10.1016/j.nmd.2016.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Tubular aggregate myopathy with features of Stormorken disease due to a new STIM1 mutation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
51
1
4

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 41 publications
(56 citation statements)
references
References 15 publications
0
51
1
4
Order By: Relevance
“…A mutation in STIM1 (D84E) resulting in TAM and Stormorken syndrome, also reported “tooth enamel hypocalcification”. Beyond this limited dental description, no other data on enamel were reported [47]. The patient showed hypocalcemia in laboratory tests which directly or indirectly affected the mineralization of the enamel as hypocalcemia in general impacts enamel [48].…”
Section: Enamel Defects In Patients With Loss-of-function Mutation Inmentioning
confidence: 99%
“…A mutation in STIM1 (D84E) resulting in TAM and Stormorken syndrome, also reported “tooth enamel hypocalcification”. Beyond this limited dental description, no other data on enamel were reported [47]. The patient showed hypocalcemia in laboratory tests which directly or indirectly affected the mineralization of the enamel as hypocalcemia in general impacts enamel [48].…”
Section: Enamel Defects In Patients With Loss-of-function Mutation Inmentioning
confidence: 99%
“…E152K is located in the EF-SAM domain, a region previously identified as being crucial for STIM1 function. So far, the role of the STIM1 EF-SAM domain has been uniquely associated with SOCE activation (Stathopulos et al, 2006;Stathopulos et al, 2008) whereas gain of function mutations in the EF-hand domain have only been associated with the constitutive activation of STIM1 and SOCE (Böhm et al, 2013;Lacruz and Feske, 2015;Noury et al, 2017). Here, we reveal a gain of function for the STIM1-E152K variant potentially caused by altered interactions with SERCA rather than enhanced EF-SAM oligomerization.…”
Section: Discussionmentioning
confidence: 67%
“…The association between STIM1 gene variants and the development of different diseases has been elucidated. Among them, we can find STIM1 variants driving to loss of function in autoimmunity and immunodeficiencies like E136X (Picard et al, 2009) and homozygous p.L74P and p.L374P (Parry et al, 2016;Vaeth et al, 2017), or reporting a gain of function like p.D84G/p.H84N/p.H109R for tubular-aggregate myopathy (Böhm et al, 2013), p.R304W for Stormorken syndrome (Misceo et al, 2014;Morin et al, 2014;Nesin et al, 2014), p.I115F (Hedberg et al, 2014) and p.D84E (Noury et al, 2017) for tubular-aggregate myopathy, and p.S88G/p.R304Q for neuromuscular malfunctions (Harris et al, 2017). The importance of Ca 2+ signaling for the regulation of pancreatic zymogen activation and the key role of STIM1 in this process suggests that variants in the STIM1 gene may also contribute to chronic pancreatitis by disturbing Ca 2+ homeostasis within the pancreatic tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Tubular aggregate myopathy essentially affects skeletal muscle, and a subset of TAM patients harboring STIM1 EF-hand mutations additionally manifested one or several signs of Stormorken syndrome (35, 8, 9, 18). Conversely, Stormorken syndrome patients carrying the most common R304W mutation usually present the full clinical picture of TAM, miosis, thrombocytopenia, hyposplenism, ichthyosis, short stature, and dyslexia (7, 1014), but individual patients with muscle weakness as the main clinical sign were also reported (9).…”
Section: Discussionmentioning
confidence: 99%